iRadimed (FRA:46K) Total Receivables: €11.60 Mil (As of Mar. 2026)


FRA:46K iRadimed Corp FRA:46K
87 GF Score
Price €84.50
GF Value €56.24
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is iRadimed Total Receivables?

iRadimed FRA:46K +1.81% 87 Total Receivables is €11.60 Mil as of Mar. 2026. GuruFocus rates FRA:46K with a GF Score™ of 87/100 and a GF Value™ of €56.24 (Significantly Overvalued). The stock has 6 warning signs investors should review.

iRadimed's Total Receivables for the quarter that ended in Mar. 2026 was €11.60 Mil.

iRadimed Total Receivables Historical Data

* Premium members only.

The historical data trend for iRadimed's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iRadimed Total Receivables Chart

iRadimed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.55 12.53 11.21 10.08 11.67

iRadimed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.75 9.47 11.81 11.67 11.60
FRA:46K
87GF Score
iRadimed Corp FRA:46K
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iRadimed Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €11.60 Mil mean?
iRadimed (FRA:46K) has a Total Receivables of €11.60 Mil as of Mar. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on iRadimed and its competitors.
Is iRadimed's Total Receivables too high?
iRadimed's current Total Receivables is €11.60 Mil. Overall, iRadimed has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iRadimed's Total Receivables compare to AVNS and LMRI?
iRadimed's Total Receivables of €11.60 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Devices & Instruments company?
A good Total Receivables depends on the Medical Devices & Instruments industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on iRadimed and its competitors. iRadimed's current Total Receivables is €11.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRadimed stock overvalued right now?
Based on GuruFocus' analysis, iRadimed (FRA:46K) is currently considered Significantly Overvalued. The stock's GF Value™ is €56.24, compared to a current price of €84.50 — trading 50.2% above its estimated fair value. The current Total Receivables is €11.60 Mil. iRadimed's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For iRadimed (FRA:46K), the current Total Receivables is €11.60 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iRadimed (FRA:46K) Overvalued in 2026?

Based on GuruFocus' analysis, iRadimed stock appears to be overvalued. The current stock price of €84.50 is trading 50.2% above its estimated GF Value™ of €56.24. GuruFocus considers iRadimed to be Significantly Overvalued.

Key valuation signals for FRA:46K:

  • Total Receivables: €11.60 Mil
  • GF Value™: €56.24 vs. price of €84.50 (50.2% above fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the FRA:46K stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

iRadimed Business Description

Other Exchanges IRMD:USA
Address 12705 Ingenuity Drive, Orlando, FL, USA, 32826
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
87GF Score

Get the complete analysis for FRA:46K

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€84.50
Price
€56.24
GF Value